Rare Diseases Symptoms Automatic Extraction

Clinical outcome of photodynamic therapy in esophageal squamous cell carcinoma.

[esophageal squamous cell carcinoma]

The aim of this study was to evaluate the feasibility and safety of photodynamic therapy (PDT) as a curative treatment option or as palliative therapy for esophageal squamous cell carcinoma. Medical records of patients who received PDT for esophageal squamous cell carcinoma, including carcinoma in situ, were reviewed retrospectively. Survival analysis was performed using the Kaplan-Meier method. A total of 31cases were treated with PDT between 2003 and 2013. Treatment was for palliative purposes in 11cases (35.5%) and for therapeutic purposes in 20cases (64.5%). We achieved 15cases (48.4%) of complete remission and 16 (51.6%) cases of partial remission during the follow-up period. There were 6 fatalities, 5 of which were related to disease progression. Complications, including benign strictures, occurred in 11cases (35.5%) but there was only 1 complication-related death. Recurrence occurred in 2 patients with complete remission. Overall survival was 31.9months for patients with complete remission and 28.2months for those with partial remission. Disease-free survival of patients with complete remission was 21.9months. Our data suggest that photodynamic therapy is a reasonable palliative treatment option with acceptable complication rates for esophageal cancer and could be performed for therapeutic purposes in cases of early esophageal cancer.